EvaluateMedTech World Preview 2016, Outlook to 2022 shows how the device industry is growing reasonably rapidly, and the calming of the M&A scene does not pose a problem for the expected growth.
Our annual report highlights trends in medtech including: consensus sales forecasts of leading industry analysts by device area to 2022; the top 20 companies in 2022; R&D spend current and future; FDA approvals; M&A; venture financing; IPOs; and enterprise value.
Worldwide medtech sales forecast to reach $529.8bn by 2022
Medtronic remains top medtech company in 2022; sales forecast to reach $39.9bn
M&A activity in H1 2016 slumps 79% to $17bn following 2015’s flurry of mega mergers
Medtech R&D spend forecast to grow by 4.3% per annum to $34.0bn in 2022
Number of first-time PMAs and HDEs hits a ten year high in 2015; 510(k) clearances decrease 6% to 3,064
View EvaluateMedTech World Preview 2016, Outlook to 2022 Executive Summary
